This case reports successful recovery of cardiac function following veno-arterial ECMO in a patient with cardiogenic shock, highlighting the role of medical therapy.
Structured abstract Background Temporary mechanical circulatory support (tMCS) is a lifesaving intervention in cardiogenic shock (CS), though not without risks. Increasing attention has been given to ventricular unloading and its role in myocardial recovery, particularly in reversible cardiomyopathies. Case Summary A 35-year-old man presenting with CS was initially treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and Impella (ECPELLA). Due to complications, support was escalated to Levitronix BiVAD. After five months of support and optimized medical therapy, substantial myocardial recovery enabled weaning from MCS and successful hospital discharge. Discussion MCS provides critical time to investigate the underlying cause of CS and assess the potential for recovery. This case illustrates how MCS can be both lifesaving and a platform for ventricular unloading and neurohormonal optimization. Although full recovery is rare in severe cases, such strategies may improve cardiac function and enable successful weaning from support.
No takes yet. Share an insight, caveat, or question.
Miguel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: